Guo Z Y, Feng J X, Zhang L J, Zhou Y B, Zhou J, Yang K, Liu Y, Lin D D, Liu J, Dong Y, Wang T P, Wen L Y, Ji M J, Wu Z D, Jiang Q W, Liang S, Guo J, Cao C L, Xu J, Lü S, Li S Z, Zhou X N
National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research), National Health Commission Key Laboratory of Parasite and Vector Biology, WHO Collaborating Centre for Tropical Diseases, National Center for International Research on Tropical Diseases, Shanghai 200025, China.
School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Tropical Disease Research Center, China.
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2022 Jul 6;34(3):217-222. doi: 10.16250/j.32.1374.2022113.
On February 2022, WHO released the evidence-based guideline on control and elimination of human schistosomiasis, with aims to guide the elimination of schistosomiasis as a public health problem in disease-endemic countries by 2030 and promote the interruption of schistosomiasis transmission across the world. Based on the One Health concept, six evidence-based recommendations were proposed in this guideline. This article aims to analyze the feasibility of key aspects of this guideline in Chinese national schistosomiasis control program and illustrate the significance to guide the future actions for Chinese national schistosomiasis control program. Currently, the One Health concept has been embodied in the Chinese national schistosomiasis control program. Based on this new WHO guideline, the following recommendations are proposed for the national schistosomiasis control program of China: (1) improving the systematic framework building, facilitating the agreement of the cross-sectoral consensus, and building a high-level leadership group; (2) optimizing the current human and livestock treatments in the national schistosomiasis control program of China; (3) developing highly sensitive and specific diagnostics and the framework for verifying elimination of schistosomiasis; (4) accelerating the progress towards elimination of schistosomiasis and other parasitic diseases through integrating the national control programs for other parasitic diseases.
2022年2月，世界卫生组织发布了关于控制和消除人体血吸虫病的循证指南，旨在指导疾病流行国家到2030年消除作为公共卫生问题的血吸虫病，并促进在全球范围内阻断血吸虫病传播。基于“同一健康”理念，该指南提出了六项循证建议。本文旨在分析该指南关键方面在中国国家血吸虫病防治规划中的可行性，并阐述其对指导中国国家血吸虫病防治规划未来行动的意义。目前，“同一健康”理念已在中国国家血吸虫病防治规划中得到体现。基于世界卫生组织的这一新指南，为中国国家血吸虫病防治规划提出以下建议：（1）完善系统框架建设，促进跨部门共识达成，建立高层领导小组；（2）优化中国国家血吸虫病防治规划中现有的人群和家畜治疗措施；（3）开发高灵敏度和特异性的诊断方法以及血吸虫病消除验证框架；（4）通过整合其他寄生虫病国家防治规划，加快实现血吸虫病和其他寄生虫病的消除进程。
